EUROPEAN JOURNAL OF PHARMACOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2197594, encodeId=ab8d219e5949a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理学;免疫与感染 经验分享：4.30投稿 5.15给了小修，5.17给它返过去 5.25小修，5.26立马返过去 5.30就online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2d18409638, createdName=ms2000001631952860, createdTime=Tue Apr 09 14:12:40 CST 2024, time=2024-04-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157643, encodeId=cf4d215e64338, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：小分子化合物 经验分享：4月21号投稿，6月16给的一审意见，8月14号大修修回。现在9月14号了，一个月了音讯全无，石沉大海。在公众号查了一下状态，没有在审的审稿人，感觉像之前的审稿人鸽了在重新找审稿人。等着毕业呢，真的崩溃，着急啊。有没有一样情况的啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b395399571, createdName=momo, createdTime=Thu Sep 14 10:58:30 CST 2023, time=2023-09-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2171602, encodeId=8c4421e16025d, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：回修后decision in process一个月了，催稿只说让等，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ceb8715921, createdName=ms3000000801940850, createdTime=Wed Nov 29 04:31:16 CST 2023, time=2023-11-29, status=1, ipAttribution=湖北省)]

2024-05-07 阜新学来自四川省

近期decision in process需要等多久啊，8天了没动静，有点着急

37 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2197594, encodeId=ab8d219e5949a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理学;免疫与感染 经验分享：4.30投稿 5.15给了小修，5.17给它返过去 5.25小修，5.26立马返过去 5.30就online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2d18409638, createdName=ms2000001631952860, createdTime=Tue Apr 09 14:12:40 CST 2024, time=2024-04-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157643, encodeId=cf4d215e64338, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：小分子化合物 经验分享：4月21号投稿，6月16给的一审意见，8月14号大修修回。现在9月14号了，一个月了音讯全无，石沉大海。在公众号查了一下状态，没有在审的审稿人，感觉像之前的审稿人鸽了在重新找审稿人。等着毕业呢，真的崩溃，着急啊。有没有一样情况的啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b395399571, createdName=momo, createdTime=Thu Sep 14 10:58:30 CST 2023, time=2023-09-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2171602, encodeId=8c4421e16025d, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：回修后decision in process一个月了，催稿只说让等，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ceb8715921, createdName=ms3000000801940850, createdTime=Wed Nov 29 04:31:16 CST 2023, time=2023-11-29, status=1, ipAttribution=湖北省)]

2024-07-09 ms9000000336335389 来自广东省

请问现在一审后DIP多久啊，已经九天了

40 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2197594, encodeId=ab8d219e5949a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理学;免疫与感染 经验分享：4.30投稿 5.15给了小修，5.17给它返过去 5.25小修，5.26立马返过去 5.30就online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2d18409638, createdName=ms2000001631952860, createdTime=Tue Apr 09 14:12:40 CST 2024, time=2024-04-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157643, encodeId=cf4d215e64338, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：小分子化合物 经验分享：4月21号投稿，6月16给的一审意见，8月14号大修修回。现在9月14号了，一个月了音讯全无，石沉大海。在公众号查了一下状态，没有在审的审稿人，感觉像之前的审稿人鸽了在重新找审稿人。等着毕业呢，真的崩溃，着急啊。有没有一样情况的啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b395399571, createdName=momo, createdTime=Thu Sep 14 10:58:30 CST 2023, time=2023-09-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2171602, encodeId=8c4421e16025d, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：回修后decision in process一个月了，催稿只说让等，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ceb8715921, createdName=ms3000000801940850, createdTime=Wed Nov 29 04:31:16 CST 2023, time=2023-11-29, status=1, ipAttribution=湖北省)]

2024-05-21 ms8000000941838223 来自北京

二审后DIP8天了，hope

34 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2197594, encodeId=ab8d219e5949a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理学;免疫与感染 经验分享：4.30投稿 5.15给了小修，5.17给它返过去 5.25小修，5.26立马返过去 5.30就online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2d18409638, createdName=ms2000001631952860, createdTime=Tue Apr 09 14:12:40 CST 2024, time=2024-04-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157643, encodeId=cf4d215e64338, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：小分子化合物 经验分享：4月21号投稿，6月16给的一审意见，8月14号大修修回。现在9月14号了，一个月了音讯全无，石沉大海。在公众号查了一下状态，没有在审的审稿人，感觉像之前的审稿人鸽了在重新找审稿人。等着毕业呢，真的崩溃，着急啊。有没有一样情况的啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b395399571, createdName=momo, createdTime=Thu Sep 14 10:58:30 CST 2023, time=2023-09-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2171602, encodeId=8c4421e16025d, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：回修后decision in process一个月了，催稿只说让等，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ceb8715921, createdName=ms3000000801940850, createdTime=Wed Nov 29 04:31:16 CST 2023, time=2023-11-29, status=1, ipAttribution=湖北省)]

2024-07-08 zhanghanluck 来自云南省

请问这个期刊对WB是什么要求

25 0

[GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2197594, encodeId=ab8d219e5949a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理学;免疫与感染 经验分享：4.30投稿 5.15给了小修，5.17给它返过去 5.25小修，5.26立马返过去 5.30就online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2d18409638, createdName=ms2000001631952860, createdTime=Tue Apr 09 14:12:40 CST 2024, time=2024-04-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157643, encodeId=cf4d215e64338, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：小分子化合物 经验分享：4月21号投稿，6月16给的一审意见，8月14号大修修回。现在9月14号了，一个月了音讯全无，石沉大海。在公众号查了一下状态，没有在审的审稿人，感觉像之前的审稿人鸽了在重新找审稿人。等着毕业呢，真的崩溃，着急啊。有没有一样情况的啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b395399571, createdName=momo, createdTime=Thu Sep 14 10:58:30 CST 2023, time=2023-09-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2171602, encodeId=8c4421e16025d, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：回修后decision in process一个月了，催稿只说让等，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ceb8715921, createdName=ms3000000801940850, createdTime=Wed Nov 29 04:31:16 CST 2023, time=2023-11-29, status=1, ipAttribution=湖北省)]

2024-07-06 ms8000001555903844 来自北京

一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊

30 0

[GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2197594, encodeId=ab8d219e5949a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理学;免疫与感染 经验分享：4.30投稿 5.15给了小修，5.17给它返过去 5.25小修，5.26立马返过去 5.30就online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2d18409638, createdName=ms2000001631952860, createdTime=Tue Apr 09 14:12:40 CST 2024, time=2024-04-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157643, encodeId=cf4d215e64338, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：小分子化合物 经验分享：4月21号投稿，6月16给的一审意见，8月14号大修修回。现在9月14号了，一个月了音讯全无，石沉大海。在公众号查了一下状态，没有在审的审稿人，感觉像之前的审稿人鸽了在重新找审稿人。等着毕业呢，真的崩溃，着急啊。有没有一样情况的啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b395399571, createdName=momo, createdTime=Thu Sep 14 10:58:30 CST 2023, time=2023-09-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2171602, encodeId=8c4421e16025d, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：回修后decision in process一个月了，催稿只说让等，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ceb8715921, createdName=ms3000000801940850, createdTime=Wed Nov 29 04:31:16 CST 2023, time=2023-11-29, status=1, ipAttribution=湖北省)]

2024-06-09 ms8000001555903844 来自辽宁省

被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗

26 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2197594, encodeId=ab8d219e5949a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理学;免疫与感染 经验分享：4.30投稿 5.15给了小修，5.17给它返过去 5.25小修，5.26立马返过去 5.30就online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2d18409638, createdName=ms2000001631952860, createdTime=Tue Apr 09 14:12:40 CST 2024, time=2024-04-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157643, encodeId=cf4d215e64338, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：小分子化合物 经验分享：4月21号投稿，6月16给的一审意见，8月14号大修修回。现在9月14号了，一个月了音讯全无，石沉大海。在公众号查了一下状态，没有在审的审稿人，感觉像之前的审稿人鸽了在重新找审稿人。等着毕业呢，真的崩溃，着急啊。有没有一样情况的啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b395399571, createdName=momo, createdTime=Thu Sep 14 10:58:30 CST 2023, time=2023-09-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2171602, encodeId=8c4421e16025d, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：回修后decision in process一个月了，催稿只说让等，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ceb8715921, createdName=ms3000000801940850, createdTime=Wed Nov 29 04:31:16 CST 2023, time=2023-11-29, status=1, ipAttribution=湖北省)]

2024-06-10 Spiriting 来自山东省

收中药单体的肿瘤研究吗？

27 0

[GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2197594, encodeId=ab8d219e5949a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理学;免疫与感染 经验分享：4.30投稿 5.15给了小修，5.17给它返过去 5.25小修，5.26立马返过去 5.30就online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2d18409638, createdName=ms2000001631952860, createdTime=Tue Apr 09 14:12:40 CST 2024, time=2024-04-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157643, encodeId=cf4d215e64338, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：小分子化合物 经验分享：4月21号投稿，6月16给的一审意见，8月14号大修修回。现在9月14号了，一个月了音讯全无，石沉大海。在公众号查了一下状态，没有在审的审稿人，感觉像之前的审稿人鸽了在重新找审稿人。等着毕业呢，真的崩溃，着急啊。有没有一样情况的啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b395399571, createdName=momo, createdTime=Thu Sep 14 10:58:30 CST 2023, time=2023-09-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2171602, encodeId=8c4421e16025d, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：回修后decision in process一个月了，催稿只说让等，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ceb8715921, createdName=ms3000000801940850, createdTime=Wed Nov 29 04:31:16 CST 2023, time=2023-11-29, status=1, ipAttribution=湖北省)]

2024-04-09 ms2000001631952860 来自浙江省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：药理学;免疫与感染
经验分享：4.30投稿 5.15给了小修，5.17给它返过去 5.25小修，5.26立马返过去 5.30就online

41 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2197594, encodeId=ab8d219e5949a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理学;免疫与感染 经验分享：4.30投稿 5.15给了小修，5.17给它返过去 5.25小修，5.26立马返过去 5.30就online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2d18409638, createdName=ms2000001631952860, createdTime=Tue Apr 09 14:12:40 CST 2024, time=2024-04-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157643, encodeId=cf4d215e64338, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：小分子化合物 经验分享：4月21号投稿，6月16给的一审意见，8月14号大修修回。现在9月14号了，一个月了音讯全无，石沉大海。在公众号查了一下状态，没有在审的审稿人，感觉像之前的审稿人鸽了在重新找审稿人。等着毕业呢，真的崩溃，着急啊。有没有一样情况的啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b395399571, createdName=momo, createdTime=Thu Sep 14 10:58:30 CST 2023, time=2023-09-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2171602, encodeId=8c4421e16025d, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：回修后decision in process一个月了，催稿只说让等，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ceb8715921, createdName=ms3000000801940850, createdTime=Wed Nov 29 04:31:16 CST 2023, time=2023-11-29, status=1, ipAttribution=湖北省)]

2023-09-14 momo 来自山东省

审稿速度:12.0 | 投稿命中率:75.0
偏重的研究方向：小分子化合物
经验分享：4月21号投稿，6月16给的一审意见，8月14号大修修回。现在9月14号了，一个月了音讯全无，石沉大海。在公众号查了一下状态，没有在审的审稿人，感觉像之前的审稿人鸽了在重新找审稿人。等着毕业呢，真的崩溃，着急啊。有没有一样情况的啊。

73 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2197594, encodeId=ab8d219e5949a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理学;免疫与感染 经验分享：4.30投稿 5.15给了小修，5.17给它返过去 5.25小修，5.26立马返过去 5.30就online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2d18409638, createdName=ms2000001631952860, createdTime=Tue Apr 09 14:12:40 CST 2024, time=2024-04-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157643, encodeId=cf4d215e64338, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：小分子化合物 经验分享：4月21号投稿，6月16给的一审意见，8月14号大修修回。现在9月14号了，一个月了音讯全无，石沉大海。在公众号查了一下状态，没有在审的审稿人，感觉像之前的审稿人鸽了在重新找审稿人。等着毕业呢，真的崩溃，着急啊。有没有一样情况的啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b395399571, createdName=momo, createdTime=Thu Sep 14 10:58:30 CST 2023, time=2023-09-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2171602, encodeId=8c4421e16025d, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：回修后decision in process一个月了，催稿只说让等，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ceb8715921, createdName=ms3000000801940850, createdTime=Wed Nov 29 04:31:16 CST 2023, time=2023-11-29, status=1, ipAttribution=湖北省)]

2023-11-29 ms3000000801940850 来自湖北省

审稿速度:2.0
偏重的研究方向：心血管病
经验分享：回修后decision in process一个月了，催稿只说让等，希望有好消息

54 7

展开7条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务